Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Paul de Deyn

Showing results (1-10 of 229) with videos related to

Pageof 23
Sort By:
Nature Reviews. Neurology|September 16, 2015
Dementia: Cerebrospinal fluid biomarkers in dementiasPeter Paul De Deyn
Medical Hypotheses|July 25, 2018
The putative glymphatic signature of chronic fatigue syndrome: A new view on the disease pathogenesis and therapyPeter Wostyn, Peter Paul De Deyn
Biomarkers in Medicine|September 5, 2017
Intracranial pressure-induced optic nerve sheath response as a predictive biomarker for optic disc edema in astronautsPeter Wostyn, Peter Paul De Deyn
European Psychiatry : the Journal of the Association of European Psychiatrists|January 18, 2006
Risperidone in the management of agitation and aggression associated with psychiatric disordersPeter Paul De Deyn, Jan Buitelaar
Expert Opinion on Drug Discovery|December 15, 2016
Non human primate models for Alzheimer's disease-related research and drug discoveryDebby Van Dam, Peter Paul De Deyn
British Journal of Pharmacology|March 5, 2011
Animal models in the drug discovery pipeline for Alzheimer's diseaseDebby Van Dam, Peter Paul De Deyn
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 13, 2005
Cognitive evaluation of disease-modifying efficacy of galantamine and memantine in the APP23 modelDebby Van Dam, Peter Paul De Deyn
Nature Reviews. Drug Discovery|November 3, 2006
Drug discovery in dementia: the role of rodent modelsDebby Van Dam, Peter Paul De Deyn
Perspectives in Medicinal Chemistry|April 14, 2011
Choroidal Proteins Involved in Cerebrospinal Fluid Production may be Potential Drug Targets for Alzheimer's Disease TherapyPeter Wostyn, Kurt Audenaert, Peter Paul De Deyn
Medical Hypotheses|January 9, 2010
Alzheimer's disease: cerebral glaucoma?Peter Wostyn, Kurt Audenaert, Peter Paul De Deyn
Pageof 23

Showing results (1-10 of 229) with videos related to

Sort By:
Pageof 23
Nature Reviews. Neurology|September 16, 2015
Dementia: Cerebrospinal fluid biomarkers in dementiasPeter Paul De Deyn
Medical Hypotheses|July 25, 2018
The putative glymphatic signature of chronic fatigue syndrome: A new view on the disease pathogenesis and therapyPeter Wostyn, Peter Paul De Deyn
Biomarkers in Medicine|September 5, 2017
Intracranial pressure-induced optic nerve sheath response as a predictive biomarker for optic disc edema in astronautsPeter Wostyn, Peter Paul De Deyn
European Psychiatry : the Journal of the Association of European Psychiatrists|January 18, 2006
Risperidone in the management of agitation and aggression associated with psychiatric disordersPeter Paul De Deyn, Jan Buitelaar
Expert Opinion on Drug Discovery|December 15, 2016
Non human primate models for Alzheimer's disease-related research and drug discoveryDebby Van Dam, Peter Paul De Deyn
British Journal of Pharmacology|March 5, 2011
Animal models in the drug discovery pipeline for Alzheimer's diseaseDebby Van Dam, Peter Paul De Deyn
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 13, 2005
Cognitive evaluation of disease-modifying efficacy of galantamine and memantine in the APP23 modelDebby Van Dam, Peter Paul De Deyn
Nature Reviews. Drug Discovery|November 3, 2006
Drug discovery in dementia: the role of rodent modelsDebby Van Dam, Peter Paul De Deyn
Perspectives in Medicinal Chemistry|April 14, 2011
Choroidal Proteins Involved in Cerebrospinal Fluid Production may be Potential Drug Targets for Alzheimer's Disease TherapyPeter Wostyn, Kurt Audenaert, Peter Paul De Deyn
Medical Hypotheses|January 9, 2010
Alzheimer's disease: cerebral glaucoma?Peter Wostyn, Kurt Audenaert, Peter Paul De Deyn
Pageof 23